RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Net income

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Jun 30, 20251,401+37.20%
Jun 30, 20241,021+13.75%
Jun 30, 2023898+15.15%
Jun 30, 2022779+64.26%
Jun 30, 2021475-23.67%
Jun 30, 2020622+53.65%
Jun 30, 2019405+28.20%
Jun 30, 2018316-7.80%
Jun 30, 2017342-2.87%
Jun 30, 2016352-0.14%
Jun 30, 2015353+2.20%
Jun 30, 2014345+12.42%
Jun 30, 2013307+20.52%
Jun 30, 2012255+12.28%
Jun 30, 2011227

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)